Page last updated: 2024-09-03

dansyllysine and Leukemia

dansyllysine has been researched along with Leukemia in 1 studies

*Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Humphries, GM; Lovejoy, JP1

Other Studies

1 other study(ies) available for dansyllysine and Leukemia

ArticleYear
Cholesterol-free phospholipid domains may be the membrane feature selected by N epsilon-dansyl-L-lysine and merocyanine 540.
    Biochemical and biophysical research communications, 1983, Mar-16, Volume: 111, Issue:2

    Topics: Animals; Fluorescent Dyes; Humans; Leukemia; Lysine; Membrane Lipids; Mice; Mice, Inbred BALB C; Phospholipids; Pyrimidinones

1983